Letter to the editor regarding "Value of C-reactive protein/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease - A data from multi-institutional study in China"
| Errataetall: |
CommentOn: Int Immunopharmacol. 2020 Dec;89(Pt A):107037. - PMID 33242833 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:95 |
|---|---|
| Enthalten in: |
International immunopharmacology - 95(2021) vom: 20. Juni, Seite 107632 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Liu, Xiaoliang [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
9007-41-4 |
|---|
| Anmerkungen: |
Date Completed 05.07.2021 Date Revised 05.07.2021 published: Print-Electronic CommentOn: Int Immunopharmacol. 2020 Dec;89(Pt A):107037. - PMID 33242833 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.intimp.2021.107632 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM324565526 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM324565526 | ||
| 003 | DE-627 | ||
| 005 | 20231225190605.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.intimp.2021.107632 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1081.xml |
| 035 | |a (DE-627)NLM324565526 | ||
| 035 | |a (NLM)33903075 | ||
| 035 | |a (PII)S1567-5769(21)00268-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Liu, Xiaoliang |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Letter to the editor regarding "Value of C-reactive protein/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease - A data from multi-institutional study in China" |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.07.2021 | ||
| 500 | |a Date Revised 05.07.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Int Immunopharmacol. 2020 Dec;89(Pt A):107037. - PMID 33242833 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Albumins |2 NLM | |
| 650 | 7 | |a Immunoglobulins, Intravenous |2 NLM | |
| 650 | 7 | |a C-Reactive Protein |2 NLM | |
| 650 | 7 | |a 9007-41-4 |2 NLM | |
| 700 | 1 | |a Zhou, Kaiyu |e verfasserin |4 aut | |
| 700 | 1 | |a Hua, Yimin |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Chuan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International immunopharmacology |d 2001 |g 95(2021) vom: 20. Juni, Seite 107632 |w (DE-627)NLM112639542 |x 1878-1705 |7 nnns |
| 773 | 1 | 8 | |g volume:95 |g year:2021 |g day:20 |g month:06 |g pages:107632 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.intimp.2021.107632 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 95 |j 2021 |b 20 |c 06 |h 107632 | ||